Abstract
Cap43 is a protein whose RNA is induced under conditions of severe hypoxia or prolonged elevations of intracellular calcium. Additionally, Ni and Co also induce Cap43 because they produce a state of hypoxia in cells. Cap43 protein is expressed at low levels in normal tissues; however, in a variety of cancers, including lung, brain, melanoma, liver, prostate, breast, and renal cancers, Cap43 protein is overexpressed in cancer cells. The low level of expression of Cap43 in some normal tissues compared with their cancerous counterparts, combined with the high stability of Cap43 protein and mRNA, makes the Cap43 gene a new, important cancer marker. We hypothesize that the mechanism of Cap43 overexpression in cancer cells involves a state of hypoxia characteristic of cancer cells where the Cap43 protein becomes a signature for this hypoxic state.
MeSH Terms
Biomarkers, Tumor/analysis
Blotting, Northern
Cell Cycle Proteins
Cell Hypoxia
Colonic Neoplasms/genetics,physiopathology
DNA-Binding Proteins/pharmacology
Gene Expression Regulation
Humans
Hypoxia-Inducible Factor 1
Hypoxia-Inducible Factor 1, alpha Subunit
Intracellular Signaling Peptides and Proteins
Lung Neoplasms/genetics,physiopathology
Nuclear Proteins/pharmacology
Protein Biosynthesis
Proteins
RNA, Messenger/analysis
Transcription Factors
Tumor Cells, Cultured
Chemicals
Biomarkers, Tumor
Cell Cycle Proteins
DNA-Binding Proteins
HIF1A protein, human
Hypoxia-Inducible Factor 1
Hypoxia-Inducible Factor 1, alpha Subunit
Intracellular Signaling Peptides and Proteins
N-myc downstream-regulated gene 1 protein
Nuclear Proteins
Proteins
RNA, Messenger
Transcription Factors
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Cangul Hakan
Department of Environmental Medicine, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA.
Salnikow Konstantin
Yee Herman
Zagzag David
Commes Therese
Costa Max
References (16)
16 references, click to expand
-
Carcinogenic nickel induces genes involved with hypoxic stress.
Cancer Res. 2000 Jan 1;60(1):38-41
PMID: 10646848
-
Role of Ca(2+) in the regulation of nickel-inducible Cap43 gene expression.
Toxicol Appl Pharmacol. 1999 Oct 15;160(2):127-32
PMID: 10527911
-
In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in human normal tissues.
J Histochem Cytochem. 2001 Feb;49(2):229-36
PMID: 11156691
-
Hypoxia inhibits G1/S transition through regulation of p27 expression.
J Biol Chem. 2001 Mar 16;276(11):7919-26
PMID: 11112789
-
A 24-base-pair sequence 3' to the human erythropoietin gene contains a hypoxia-responsive transcriptional enhancer.
Proc Natl Acad Sci U S A. 1993 May 1;90(9):3928-32
PMID: 8387202
-
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Cancer Res. 1994 Sep 15;54(18):4855-78
PMID: 8069852
-
Sphingosine and sphingosine 1-phosphate differentially modulate platelet-derived growth factor-BB-induced Ca2+ signaling in transformed oligodendrocytes.
J Biol Chem. 1996 Jan 5;271(1):295-301
PMID: 8550576
-
Structural and functional analysis of hypoxia-inducible factor 1.
Kidney Int. 1997 Feb;51(2):553-5
PMID: 9027737
-
Tumor-specific expression of cytochrome P450 CYP1B1.
Cancer Res. 1997 Jul 15;57(14):3026-31
PMID: 9230218
-
A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms.
Lab Invest. 1997 Jul;77(1):85-92
PMID: 9251681
-
Loss of function and p53 protein stabilization.
Oncogene. 1997 Oct 16;15(16):1889-93
PMID: 9365234
-
Cap43, a novel gene specifically induced by Ni2+ compounds.
Cancer Res. 1998 May 15;58(10):2182-9
PMID: 9605764
-
HIF-1 alpha is required for solid tumor formation and embryonic vascularization.
EMBO J. 1998 Jun 1;17(11):3005-15
PMID: 9606183
-
Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage.
Cancer Res. 1998 Oct 1;58(19):4439-44
PMID: 9766676
-
Nickel-induced transformation shifts the balance between HIF-1 and p53 transcription factors.
Carcinogenesis. 1999 Sep;20(9):1819-23
PMID: 10469629
-
Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer.
Cancer Res. 2000 Oct 15;60(20):5630-4
PMID: 11059752